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Summary
Astrocytes are key cells in brain aging, helping neurons to
undertake healthy aging or otherwise letting them enter into a
spiral of neurodegeneration. We aimed to characterize astrocytes
cultured from senescence-accelerated prone 8 (SAMP8) mice, a
mousemodel of brain pathological aging, alongwith the effects of
caloric restriction, the most effective rejuvenating treatment
known so far. Analysis of the transcriptomic profiles of SAMP8
astrocytes cultured in control conditions and treated with caloric
restriction serum was performed using mRNA microarrays. A
decrease in mitochondrial and ribosome mRNA, which was
restored by caloric restriction, confirmed the age-related profile
of SAMP8 astrocytes and the benefits of caloric restriction. An
amelioration of antioxidant and neurodegeneration-related path-
ways confirmed the brain benefits of caloric restriction. Studies of
oxidative stress and mitochondrial function demonstrated a
reduction of oxidative damage and partial improvement of mito-
chondria after caloric restriction. In summary, caloric restriction
showed a significant tendency to normalize pathologically aged
astrocytes through the activation of pathways that are protective
against the age-related deterioration of brain physiology.
Key words: astrocytes; caloric restriction; mitochondria; oxi-
dative stress; RNA microarrays; SAMP8.
Introduction
Astrocytes are now known to be more relevant to brain function than
once thought. Their central role in brain homeostasis (Belanger et al.,
2011) and their partnering with neurons in synapsis transmission (Perea
et al., 2009) implies their involvement in all major aspects of brain health
and disease. Astrocytes are intrinsically neuroprotective, but their
defense mechanisms can be overwhelmed in pathological brain condi-
tions. In normal aging, astrocytes are exposed to an increased oxidative
environment that might decrease their neuroprotective capacity, as
demonstrated in aged astrocyte cell models (Pertusa et al., 2007; Garcıa-
Matas et al., 2008). Long-term reactive astrocytes in age-associated
neurodegenerative diseases such as Alzheimer’s disease (AD) lose their
neuroprotective capacity and contribute to the brain pathology (Li et al.,
2011). However, astrocytes are more resilient than neurons against age-
associated pathology and a range of brain injuries. Therefore, restoring
or potentiating their natural capacity for neuroprotection may be an
effective strategy against neurodegeneration. For instance, the overex-
pression of glial cell-derived neurotrophic factor (GDNF) in hippocampal
astrocytes restored cognitive loss in aged rats (Pertusa et al., 2008).
Understanding the underlying mechanisms of response of astrocytes to
antiaging therapies will help to determine the best scenario for
maintaining human cognitive capacity until an old age.
Caloric restriction (CR) is the most effective antiaging therapy to date.
A reduction of 10–40% in food consumption while maintaining
adequate nutrients increases the average and maximum lifespan in
many experimental model organisms. The exact mechanisms of CR have
yet to be elucidated, but they appear to involve highly conserved
mechanisms of stress response (Sinclair, 2005). CR reduces the metabolic
rate and oxidative damage and induces many physiological changes
opposed to the development of chronic age-associated diseases (Red-
man & Ravussin, 2011). However, a CR-induced increase in longevity has
yet to be demonstrated in nonhuman primates (Mattison et al., 2012)
and humans. Interestingly, CR delays the age of onset of age-associated
pathologies in all species analyzed, including humans. With regard to
brain function, Rhesus monkeys subjected to CR showed diminished
age-related brain atrophy in key regions of motor and executive
functions (Colman et al., 2009). Furthermore, a study in healthy humans
showed that CR improves memory in the elderly (Witte et al., 2009).
Astrocytes appear to be responsive to CR intervention in vivo. Healthy
rats showed an improvement of astroglial function in the hippocampus
(Ribeiro et al., 2009), and transgenic mice for AD (APP + PS1) showed
decreased astrocyte activation (Patel et al., 2005) after CR treatment. If
CR is mostly a metabolic therapy, astrocytes would be the main
mediators of the beneficial changes of this therapy in the brain, playing
an important regulatory role in brain metabolism (Belanger et al., 2011).
We wished to study the changes induced by CR in senescent and healthy
astrocyte cells to evaluate the usefulness of this therapy in brain
rejuvenation and defense against age-associated AD-type degeneration.
We chose the senescence-accelerated prone 8 (SAMP8) mouse as a
source of senescent astrocytes. SAMP8 is an inbred strain obtained
through phenotypic selection that presents learning and memory
deficits, anxiety, impaired immune system and brain pathologies that
worsen with age: mitochondrial dysfunction, oxidative stress, tau
hyperphosphorylation, inflammation and amyloid-beta deposition (Tom-
obe & Nomura, 2009). SAMP8 mice have shown improved cognitive
performance after CR treatment (Komatsu et al., 2008). Cultured
SAMP8 astrocytes have a senescence phenotype with markers of both,
aging and AD (Garcıa-Matas et al., 2008; Dıez-Vives et al., 2009).
Therefore, we undertook a gene expression microarray study of cerebral
Correspondence
Rafael de Cabo, Ph.D., Experimental Gerontology Section, TGB, NIA, NIH, Suite
100/Room 9C218, 251 Bayview Blvd., Baltimore, MD 21224, USA.
Tel.: 410 558 8510; fax: 410 558 8302; e-mail: decabora@grc.nia.nih.gov
*These authors contributed equally to this work.
†These authors shared senior authorship.
Accepted for publication 15 June 2014
334 ª 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
Aging Cell (2015) 14, pp334–344 Doi: 10.1111/acel.12259
Ag
in
g 
Ce
ll
cortical astrocytes cultured from SAMP8 mice and its control strain
senescence-resistant 1 (SAMR1) mice. To induce a CR phenotype in
both, SAMP8 and SAMR1 astrocytes, we used a previously developed in
vitro model system using serum from rodents subjected to CR (de Cabo
et al., 2003). Treatment with CR serum will induce physiological and
gene expression changes related to CR mechanisms in astrocytes
cultured in vitro, as previously demonstrated in rodent hepatocytes
and fibroblasts and diverse human cell lines (de Cabo et al., 2003; Hyun
et al., 2006; Allard et al., 2008). We analyzed the differential transcrip-
tomic changes induced in SAMP8 vs. SAMR1 astrocytes by CR treatment.
We anticipated that many of the changes would appear in mitochondria-
related pathways, as these cell organelles are hypothesized to be the
main drivers of biological aging. Furthermore, mitochondria are
proposed to play a significant role in pathological aging and neurode-
generation, while SAMP8 astrocytes show decreased mitochondrial
membrane potential and increased generation of reactive oxygen species
(ROS) (Garcıa-Matas et al., 2008). Therefore, we also analyzed the
beneficial effects of CR against the functional alterations of mitochon-
dria and oxidative stress of SAMP8 astrocytes.
Results
Caloric restriction induced a shift in the transcriptome of
SAMP8 astrocytes toward SAMR1 astrocytes
The gene expression profiles of the four experimental groups of
astrocyte cultures showed a significant Z score for 9709 mRNA
transcripts of the 24 613 tested (39.4%). Calculation of the Z ratios
for the pairs of groups showed differential expression in 1079 gene
transcripts (17.5%). SAMP8 showed upregulation of 504 genes and
downregulation of 312 genes in control conditions with AL treatment,
compared with SAMR1 (P8AL-R1AL). CR induced major changes in both
astrocyte types. CR-treated SAMR1 had 257 upregulated and 152
downregulated genes (R1CR-R1AL). CR-treated SAMP8 had 189 upreg-
ulated and 183 downregulated genes (P8CR-P8AL). Comparison of the
astrocyte strains after CR treatment showed the upregulation of 446 and
downregulation of 327 genes in SAMP8 compared with SAMR1 (P8CR-
R1CR). See Table S1 (Supporting information) for a list of differentially
expressed transcripts.
PAGE analysis demonstrated 803 pathways with altered expression in
SAMP8 astrocytes compared with SAMR1 out of the 1689 tested
(47.6%). CR normalized 318 of the differentially expressed pathways,
namely more than a third of them. In addition, 203 new pathways
showed a significant Z score after CR, but with overwhelmingly mild
differences in expression. With regard to the specific effects of CR in each
strain, the treatment induced more changes in SAMP8 than in SAMR1,
with 807 and 664 altered pathways, respectively. These CR-induced
changes on coincident pathways in the two strains were in the opposite
direction of change in 53% of cases. Collectively, CR induced differential
changes in the SAMP8 and SAMR1 transcriptomes and made SAMP8
astrocytes more similar to SAMR1 ones than in control conditions (Fig. S1,
Supporting information). Notably, the upregulation of gene sets such as
Aging brain up (Z score P8AL-R1AL: 3.9999) and AD up (Z score P8AL-
R1AL: 5.0492) in SAMP8 was totally prevented by CR treatment (see
Table S2, Supporting information for a complete list of pathway results).
Results of the analysis of GO gene sets for biological processes are
shown in Fig. 1. A total of 151 GO terms differed between SAMP8 and
SAMR1 (P8AL-R1AL) and 99 differed after CR treatment (P8CR-R1CR),
indicating a 34% decrease. Cluster analysis for the most significant 100
GO terms showed that CR had the effect of diminishing the activity of
biological processes that was more accentuated in SAMP8 astrocytes
than in SAMR1 (Fig. 1A). Venn diagrams demonstrated that 64% of the
biological processes altered in basal conditions were not modified by CR
treatment, whereas CR induced changes in opposite direction in 62% of
the commonly affected biological processes (Fig. 1B). Those most
downregulated in SAMP8 and not restored by CR were processes
associated with immunological function and mitosis (Fig. 1C). Ribosomal
function and protein translation were highly downregulated but
protected by CR. Those most upregulated in SAMP8 compared with
SAMR1 and not protected by CR were processes of transcription and
insulin receptor signaling, even though differences were reduced after
CR as seen by the lower Z score of the ratios (P8CR-R1CR), whereas
blood vessel maturation and cell adhesion were protected. Other gene
sets also downregulated in SAMP8 but restored by CR were associated
with protein folding, transport of molecules (proton, iron ion, protein),
response to ROS and ATP synthesis (not shown, see Table S3, Supporting
information). It should be noted that glutathione metabolism was
differentially upregulated in SAMP8 by CR treatment. Other gene sets
upregulated in SAMP8 but restored by CR were associated with
organogenesis processes, extracellular matrix organization and MAPKKK
cascade signaling (Table S3, Supporting information).
The results of the analysis of GO gene sets for cellular component are
shown in Fig. S2 (Supporting information). A total of 65 GO terms
differed between SAMP8 and SAMR1 (P8AL-R1AL), and 35 differed after
CR treatment (P8CR-R1CR), namely differences decreased by 46%.
Cluster analysis of the most significant 100 GO terms showed that CR
induced many changes in SAMP8 that led to small differences, mostly
downregulation, of gene sets of the cellular components in comparison
with SAMR1 (Fig. S2A, Supporting information). Venn diagrams showed
that 54% of gene sets that differed between SAMP8 and SAMR1 in
basal conditions were not modified by CR (Fig. S2B, Supporting
information). Treatment also induced changes in opposite direction in
43% of commonly affected gene sets in the two strains. Many ribosome
and mitochondria component gene sets were highly downregulated in
SAMP8 and restored by CR (Fig. S2C, Supporting information). Some of
the extracellular matrix and membrane components that were upreg-
ulated in SAMP8 were restored by CR (i.e., proteinaceous matrix,
collagen, basement membrane) (see Table S4, Supporting information).
The results of the analysis of GO gene sets for molecular function are
shown in Fig. S3 (Supporting information). A total of 86 GO terms
differed between SAMP8 and SAMR1 (P8AL-R1AL), and 59 differed after
CR treatment (P8CR-R1CR). Cluster analysis of the most significant 100
GO terms showed that CR induced many changes in the expression of
SAMP8 gene sets, which decreased the differences between both types
of CR-treated astrocytes (Fig. S3A, Supporting information). Venn
diagrams showed that 47% of the gene sets that differed between
SAMP8 and SAMR1 in basal conditions were not modified by CR.
Treatment also induced changes in opposite direction in 67% of
commonly affected gene sets in the two strains (Fig. S3B, Supporting
information). Ribosome-related molecular functions, antioxidant activi-
ties and hydrogen ion transport were highly downregulated gene sets in
SAMP8 that were restored after CR. Molecule-binding gene sets
(protein, metal ion, nucleic acid) were upregulated in SAMP8 in basal
conditions and were mostly restored after CR treatment (Fig. S3C,
Supporting information). Extracellular matrix-upregulated gene sets
were partially protected by CR; namely longitudinal stress was protected,
but not structural integrity. Upregulated gene sets involved in the
regulation of transcription were partially normalized by CR. Quantitative
PCR data for selected genes highly upregulated or downregulated in
SAMP8 are shown in Table S6 (Supporting information).
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Caloric restriction ameliorated senescence phenotype of
SAMP8 astrocytes
Microscopical analysis did not show major changes of cellular morphol-
ogy or mitochondrial mass in SAMP8 astrocytes as compared to SAMR1
(Fig. 2A). However, SAMP8 cultures showed replicative senescence as
indicated by elevated b-galactosidase activity, which was protected by
CR treatment (Fig. 2A). Furthermore, SAMP8 astrocytes showed accu-
mulation of oxidative damage that is also associated to aging.
Nitrotyrosinated proteins detected in SAMP8 cultures were protected
by CR treatment (Fig. 2A). Quantitative changes of mRNA expression
were analyzed for representative mitochondrial complex and ribosome
(A) (B)
(C)
Fig. 1 Gene pathways of biological processes were modulated differentially in SAMP8 vs. SAMR1 astrocytes, and these differences were attenuated by caloric
restriction. (A) Hierarchical cluster of the 100 gene pathways of gene ontology (GO) gene sets for biological processes most differentially modulated between the
experimental groups. (B) Venn diagrams showing the number of pathways upregulated (upward arrow, red number), downregulated (downward arrow, green number)
or with opposed changes (black number). (C) Histograms indicating the GO terms for the top five upregulated and downregulated biological pathways between the
experimental groups.
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(A)
(B)
Fig. 2 Senescence phenotype of SAMP8 astrocytes was ameliorated by caloric restriction. (A) No distinctive morphological changes were observed by phase contrast
microscopy (PhC) in SAMP8 as compared to control strain SAMR1, but b-galactosidase (b-GAL) blue staining of the same microscopy fields indicated the presence of
replicative senescence in SAMP8 astrocytes treated with ad libitum serum (SAMP8-AL), whereas staining was greatly reduced in those treated with caloric restriction serum
(SAMP8-CR). Mitotracker green FM (MTG) stained a similar mitochondrial pattern in the different cultures (green fluorescence). Immunostaining of nitrotyrosinated proteins
(NT) was only visible (green fluorescence spots) in SAMP8-AL astrocytes, whereas that of GFAP (red fluorescence) showed similar astrocyte morphology in the different
cultures; nuclei were counterstained with TO-PRO-3 iodide (confocal images). Representative images, n = 4. (B) Gene expression of mitochondrial and antioxidant genes
measured by real-time qPCR showed a moderate increase in SAMP8 astrocytes after CR treatment. Nudfa1, Uqcrh, Cox6b1, Apt5e, and Mrpl14 encode proteins of
mitochondrial complexes I, III, IV, V, and mitochondrial ribosomes, respectively; Sod1, Gpx3, Gpx8, and Atox1 encode a variety of soluble and membrane antioxidants, and
Nudt1 a selective nucleic acid antioxidant. See Table S7 (Supporting information) for full name of genes and oligomers used. Statistics: **P < 0.01 overall effect of CR
treatment according to ANOVA, without post hoc Bonferroni’s test significance.
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components and antioxidant molecules that were increased after CR
treatment according to microarray results. These genes resulted mod-
erately upregulated as shown in Fig. 2B (ANOVA, factor treatment,
F1,56 = 7.625, P = 0.0078; without individual significant changes) and
then might help as a whole to ameliorate senescence phenotype of
SAMP8 astrocytes. Gene full names and data are shown in Table S7
(Supporting information). Next, oxidative status and mitochondrial
function were deeply analyzed as described below.
Caloric restriction reduced oxidative damage of SAMP8
astrocytes
SAMP8 astrocytes showed higher levels of ROS than SAMR1 ones
(Fig. 3A). Differences between the two cultures were smaller after
oxidative injury caused by hydrogen peroxide, which greatly increased
ROS generation as tested by DCF (ANOVA indicated an effect of strain
F1,63 = 6.412, P = 0.0138; and hydrogen peroxide F1,63 = 98.87,
P < 0.0001). SAMR1 and SAMP8 astrocytes showed similar levels of
oxygen consumption (Fig. 3B). CR treatment decreased the respiratory
rate, as expected. This decrease was significant in SAMR1, whereas
SAMP8 showed a clear trend with mean values similar to SAMR1
astrocytes (ANOVA indicated an effect of CR treatment, F1,23 = 6.009,
P = 0.0222). CR reduced ROS generation in SAMR1 astrocytes (Fig. 3C)
(ANOVA indicated the significance of strain in control and hydrogen
peroxide conditions, F1,42 = 11.24, P = 0.0017 and F1,51 = 6.269,
P = 0.0155 respectively; and an effect of CR treatment against hydrogen
peroxide, F1,51 = 6.072, P = 0.0171). The presence of oxidized proteins
was significantly higher in SAMP8 astrocytes, as shown by the analysis of
carbonyl groups (Fig. 3D). Levels of SAMP8 oxidized proteins were close
to SAMR1 values after CR treatment (ANOVA indicated significance of
strain, F1,32 = 6.729, P = 0.0142). Levels of the mitochondrial antioxi-
dant enzyme aconitase 2 showed a trend to decrease in SAMP8
astrocytes and a significant increase after CR treatment (Fig. 3E)
(ANOVA indicated an interaction of strain x treatment, F1,22 = 5.975,
P = 0.230).
Caloric restriction improved mitochondrial complex proteins
of SAMP8 astrocytes
SAMP8 astrocytes had a lower MMP than SAMR1 astrocytes, as tested
by rhodamine 123 (Fig. 4A). In addition, SAMP8 astrocytes were more
sensitive to the respiratory complex III selective inhibitor antimycin A
(Fig. 4B). Therefore, they showed a functional deficit in the respiratory
complex III. SAMP8 astrocytes tested using TMRM/NAO also showed a
decreased MMP in comparison with SAMR1 (Fig. 4C). This difference
was not ameliorated by CR (ANOVA indicated an effect of strain
F1,18 = 15.20, P = 0.0011; and no significant effect of CR treatment).
CR did not protect SAMP8 from antimycin A sensitivity either (not
shown). SAMP8 showed decreased levels of markers of mitochondrial
complexes as compared to SAMR1 that were significant for complex III,
IV and V (ANOVA, factor strain, F1,28 = 7.295, P = 0.0120,
F1,28 = 5.317, P = 0.0290 and F1,28 = 7.301, P = 0.0116, respectively).
CR induced a trend to recover complex protein levels, mainly the most
depressed complex III (Fig. 4D). NAO fluorescence as indicative of
mitochondrial mass did not show significant changes with CR (Fig. 4E).
Discussion
Astrocytes of the senescence mouse SAMP8 showed a gene expression
profile indicative of age-related cell frailty and physiological decline. A
number of genomic and proteomic studies of SAMP8 brain tissue
compared with control mouse SAMR1 have been undertaken to discern
the genetic basis of the complex phenotype of brain senescence that
paves the path to AD or other neurodegenerative diseases. A review of
the main findings concluded that SAMP8 brain shows gene expression
changes in the functional categories of neuroprotection, signal trans-
duction, protein folding and degradation, antioxidant system, energy
metabolism, immune response, cytoskeleton and transport (Butterfield &
Poon, 2005). The changes in gene expression in SAMP8 astrocytes found
in the present study generally fit into these categories. Note that the
increased expression of genes linked to pathways of both aging and AD
confirms the trend for pathological aging of the SAMP8 astrocytes.
SAMP8 astrocytes were defective in the expression of immune and
antioxidant response genes, in agreement with a frail aging phenotype
characterized by a reduced capacity to cope with cell stressors. Frailty is
induced in the process of aging by a critical lowering of the physiological
reserve capacity following a lifetime of injuries. Once the condition of
frailty is reached, cells are prone to age-related physiological decline
(Kirkland & Peterson, 2009). For instance, accumulation of oxidative
damage may lead to the exhaustion of antioxidant capacity and open the
way to age-related pathologies (Salmon et al., 2010). Similarly, immu-
nological response to antigen presentation is diminished in frail elderly
(de la Rosa et al., 2006). In the brain, astrocytes have antioxidant and
antipathogen activity. These two defense functions, the latter together
with microglia, greatly contribute to the neuroprotective role of
astrocytes. Their decline in the SAMP8 astrocytes will reduce their vital
support to neurons, consistent with the results reported in a co-culture
system (Garcıa-Matas et al., 2008).
Treatment with CR serum induced huge changes in the gene
expression of astrocytes. In control astrocytes, as expected, CR reduced
cell growth-related mechanisms and prepared the cells for survival in a
low-nutrient environment. Similarly, a previous study with a hepatoma
cell line treated with CR serum showed a gene modulation, leading to
the reduction of cell proliferation and enhanced tolerance to stress (de
Cabo et al., 2003). Notably, the effects of CR were largely opposed in
SAMP8 astrocytes compared with SAMR1, leading to a reduction in
transcriptomic differences between the two strains. For instance,
downregulation of pathways related to protein synthesis and upregu-
lation of genes related to extracellular matrix and to maturation of some
organs such as blood vessels were observed in SAMR1. Cell growth
pathways were downregulated and extracellular matrix and organ
maturation were already upregulated in SAMP8 in basal conditions. CR
generally ameliorated these changes toward healthy astrocyte levels,
although did not reverse some of the senescence markers such as the
immune deficiency shown by SAMP8 cells. Interestingly, CR reversed the
substantial decrease in gene expression found for components and
functional pathways of ribosomes. Indeed, a decrease in ribosome gene
expression has been implicated in age- and AD-related changes (Pay~ao
et al., 1998), and a decreased rate of protein synthesis has been
reported in aged mitochondria (Hudson et al., 1998). However, CR
induced a downregulation of ribosome-related genes in control SAMR1
astrocytes in agreement with a reduction in protein synthesis to lower
energy expenditure. Therefore, CR induced changes in opposite direction
in SAMP8 cells to bring their pattern of gene activation closer to that of
healthier cell conditions.
SAMP8 astrocytes showed increased ROS generation and protein
oxidation, signs of accelerated aging. Accumulation of oxidative damage
with age might derive from increased mitochondrial production of ROS
unbalanced with the cellular response to oxidative stress (Balaban et al.,
2005). Remarkably, CR specifically increased antioxidant defense gene
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pathways in SAMP8 astrocytes. Therefore, we found a decrease of
protein carbonylation and nitrosylation in CR-treated SAMP8 astrocytes
although their generation of ROS was not significantly decreased.
Interestingly, levels of the mitochondrial antioxidant enzyme aconitase 2
were higher in SAMP8 astrocytes after CR treatment. This and other
antioxidant agents would contribute to improve the redox state and
decrease the oxidative damage markers. A previous report has shown a
reduction of protein carbonyl and nitrotyrosine levels and of the lipid
peroxidation marker 8-isoprostane in a similar in vitro CR model with
human neuroblastoma SH-SY5Y cells (Hyun et al., 2006). This study had
also demonstrated an increase of antioxidant defenses and a decrease of
oxidative damage in the plasma membrane of rat brain submitted to CR.
Other authors have reported that CR treatment in vivo increases the
activity of the glutathione system and reduces ROS generation in rat
brain (Ribeiro et al., 2012).
Mitochondrial dysfunctions are believed a main contributor to age-
related oxidative stress and cell frailty. In this regard, the general
deficiencies found in mitochondrial complexes, more noticeable in
complex III, may be the basis of the senescent phenotype of SAMP8. A
decrease in complex III activity has also been reported in mitochondria
(A) (B)
(C)
(E)
(D)
Fig. 3 Caloric restriction reduced the
oxidative stress suffered by SAMP8
astrocytes. (A) SAMP8 astrocytes generated
more reactive oxygen species (ROS) than
SAMR1 astrocytes in control conditions as
measured by increased dichlorofluorescein
(DCF) fluorescence units (FU), whereas
differences between the two cell types
were minor in the presence of hydrogen
peroxide. (B) Caloric restriction (CR)
reduced the oxygen consumption of the
astrocyte cells compared with control
conditions (AL). (C) CR barely decreased the
excess ROS generated by SAMP8
astrocytes, whereas the decrease it induced
in the ROS generated by hydrogen peroxide
was only significant in control SAMR1
astrocytes. (D) CR reduced the increased
level of carbonylated proteins of SAMP8
astrocytes, as shown in representative
oxyblots. Coomassie blue staining was used
to normalize protein oxidation in an
integrated area including the two main
oxidation bands (arrows). Statistics:
*P < 0.05 vs. SAMR1; #P < 0.05, and
##P < 0.01, vs. control ad libitum (AL)
conditions by Bonferroni’s test.
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from whole-brain homogenates of SAMP8 in comparison with SAMR1 at
4 weeks of age (Fujibayashi et al., 1998). A reduced ATP content in
hippocampal tissue of aged SAMP8 (Xu et al., 2007) confirms the
progressive failure of mitochondrial function in vivo, although we did not
found a decrease of oxygen consumption in vitro. The bioenergetic
efficiency of mitochondria increases under CR, which leads to the
generation of less ROS for equivalent ATP production than in control
conditions (Lopez-Lluch et al., 2006). The CR treatment in vitro
improved the mitochondrial machinery of SAMP8, but this was not
enough to normalize mitochondrial alterations such as reduced MMP.
Indeed, CR has been reported to decrease MMP as part of the adaptive
shift in mitochondrial energy metabolism and resistance to oxidative
stress (Lopez-Lluch et al., 2006). In line with higher mitochondrial
efficiency, a decrease in oxygen consumption after CR treatment has
been shown in rat hepatocyte and human HeLa cells (Lopez-Lluch et al.,
2006) and whole-body healthy (Civitarese et al., 2007) and obese
humans (Redman & Ravussin, 2011). Metabolic adaptation in humans
accounts for a 6% reduction in sedentary energy expenditure (Redman &
Ravussin, 2011). There was around 30% decrease in oxygen consump-
tion in SAMR1 astrocytes similar to a 40% decrease previously found in
rat and human cell cultures (Lopez-Lluch et al., 2006). A decrease also
shown by SAMP8, although not statistically significant, was consistent
with some adaptive response to CR-induced changes. Furthermore, CR
induced rejuvenation effects in SAMP8 mitochondria, namely the partial
restoration of damaged organelles through the upregulation of genes
for mitochondrial components, amelioration of functional pathways and
protection against further damage through the upregulation of antiox-
idant pathways.
The adjustment of energy expenditure and general amelioration of
cellular stress responses induced by CR appears to be the basis of the
cognitive improvement reported in several mouse models of aging and
AD. Molecular mediators include neurotrophic factors, neurotransmitter
receptors, protein chaperones and mitochondrial biosynthesis regulators
(Fontan-Lozano et al., 2008). Astrocytes are deeply involved in brain
(A) (B)
(C)
(E)
(D)
Fig. 4 SAMP8 astrocytes showed
mitochondrial impairment that was partially
ameliorated by caloric restriction. (A)
SAMP8 astrocyte mitochondria had
reduced membrane potential (MMP) as
measured by rhodamine 123 (Rh123). (B)
Mitochondrial uncouplers and specific
inhibitors showed the differential sensitivity
of SAMP8 astrocytes against antimycin A,
an inhibitor of complex III, compared with
SAMR1 astrocytes. (C) Caloric restriction
(CR) barely modified MMP in comparison
with the control ad libitum (AL) treatment,
measured according to the ratio of
tetramethylrhodamine methyl ester to
nonyl acridine orange (TMRM/NAO). (D)
Mitochondrial complex proteins showed a
general trend to decrease in SAMP8 in
comparison with the SAMR1 levels. CR
improved the level of the mitochondrial
complex III protein marker in SAMP8, which
was significantly decreased, as shown in
representative immunoblots and
densitometry analysis of proteins from the
respiratory chain complexes. The
immunoreactivity of the protein bands of
adenosine triphosphate (ATP) synthase
subunit a (ATP5A, complex V), ubiquinol-
cytochrome-c reductase complex core
protein 2 (UQCRC2, complex III),
cytochrome c oxidase I (COX1, complex IV),
and NADH dehydrogenase [ubiquinone] 1 b
subcomplex subunit 8 (NDUFB8, complex I)
was normalized to that of succinate
dehydrogenase [ubiquinone] iron-sulfur
subunit (SDHB, 30 kDa subunit, complex II)
protein. (E) CR barely modified the
mitochondrial mass as measured by NAO.
Statistics: *P < 0.05 vs. SAMR1 by
Bonferroni’s test.
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functioning either by supporting neuron survival and plasticity or by
directly participating in neurotransmission pathways. Therefore, SAMP8
astrocyte amelioration by CR treatment would suggest cognitive
amelioration in SAMP8 after CR interventions in vivo. Indeed, improve-
ment in the passive avoidance test outcome by SAMP8 has been
described after a CR treatment (Komatsu et al., 2008). It has been
hypothesized that CR delays the triggering of age-related disease
including AD. SAMP8 mice show brain degeneration traits of AD (Pallas
et al., 2008) as do SAMP8 astrocyte cultures (Garcıa-Matas et al., 2008;
Dıez-Vives et al., 2009). Accordingly, we found that the activation of
gene sets related to brain aging and to AD in SAMP8 astrocytes reverted
to control values under CR treatment. In the fight against AD, CR may
have additional effects by decreasing amyloid and tau pathologies
(Halagappa et al., 2007). Some of these beneficial effects of CR are at
least partially mediated through activation of the sirtuin family gene
SIRT1 in neurons (Qin et al., 2006). However, we did not detect SIRT1
gene upregulation in CR-treated astrocytes. Similarly, other authors have
neither found increased levels of SIRT1 protein in the brain of old mice
submitted to CR (Barger et al., 2008). Accordingly, although SIRT1 has
emerged as central mediator of the antiaging CR benefits (Baur et al.,
2012), a recent report in mouse liver has demonstrated a requirement
for SIRT1 but not necessarily for an increased expression of SIRT1
(Mercken et al., 2014).
Reduction of the senescence marker b-galactosidase after CR also
indicated a rejuvenation effect in the phenotype of SAMP8 astrocytes.
Detection of lysosomal b-galactosidase is associated with replicative
senescence (Lee et al., 2006). We did not detect further senescent traits,
such as enlarged and flat cell morphology or lipofuscin depots, in
addition to the above discussed oxidative damage.
Previous studies carried out with CR serum treatment gave some clue
on the metabolites involved in its protective effects. Namely, low levels
of insulin and insulin growth factor (IGF)-1 in CR serum mediate a partial
protection against hydrogen peroxide in rat hepatoma cells (de Cabo
et al., 2003). Furthermore, IGF-1/insulin signaling is inhibited by CR in
human skeletal muscle, leading to the activation of longevity and
protection mechanisms (Mercken et al., 2013). Metabolomic
approaches have shown that serum of animals submitted to CR has a
distinctive metabolic profile added to a decrease of age-related changes
(De Guzman et al., 2013). Lipid, fatty acid, and bile acid metabolism
pathways were identified as responsive to CR in mouse serum by these
authors. Furthermore, they found a protection of age-related loss of
phospholipids involved in maintaining a low peroxidizability index of cell
membranes. Therefore, CR serum contains trophic factors and metab-
olites that induce protective pathways through changes in the activation
of many genes. The CR protective effects in SAMP8 are probably
mediated through the activation of those gene pathways discussed
above of ribosome/protein synthesis, mitochondria/bioenergetics effi-
ciency, and antioxidant defense. Overall, CR serum helped senescent
SAMP8 astrocytes to cope with adverse conditions and also had a
rejuvenating effect.
Experimental procedures
Astrocyte cultures and treatment
Primary cultures enriched in astrocytes were obtained from cerebral
cortical tissue from 2-day-old SAMP8 and SAMR1 mice. Mice were bred
in the University of Barcelona Animal House (UB, Barcelona, Spain). The
first breeding pairs were obtained from the Council for SAM Research,
Kyoto, Japan, through Harlan (Barcelona, Spain). All experimental
procedures were approved by the Ethics Committee for Animal
Experimentation (CEEA) of the University of Barcelona, Spain. Astrocyte
cultures were established as previously described (Garcıa-Matas et al.,
2008). Experiments were routinely carried out at 21 days in vitro.
Established astrocyte cultures of both SAMR1 and SAMP8 consisted of
85–90% astrocytes, 10–15% microglia and 0.1–1% oligodendroglia.
Sera from rats subjected to ad libitum (AL) diet and to CR were
obtained as described for the establishment of the CR in vitro model (de
Cabo et al., 2003). Serum was heat inactivated at 56°C prior to use in
astrocyte culture experiments. Treatment in vitro was performed by
adding 10% volume CR or AL serum onto the astrocyte culture medium
for 48 h. The different analyses were then performed in the living cells or
the cultures were collected for Western blot or mRNA microarray studies.
Analysis of microarray data
RNA was extracted from astrocyte cultures using TRIzol reagent
following the manufacturer’s instructions (Invitrogen, Carlsbad, CA,
USA). Samples were obtained from SAMP8 and SAMR1 astrocytes
treated with AL or CR serum for 48 h (n = 3 independent experiments).
Purified RNA was hybridized to a whole-genome expression microarray
(MouseRef-8 v1.1 Expression BeadChip with 24 613 gene transcripts;
Illumina, San Diego, CA, USA), following protocols listed on the Gene
Expression and Genomics Unit website at the National Institute of Aging
(http://www.grc.nia.nih.gov/branches/rrb/dna/index/protocols.htm).
Raw data were subjected to Z normalization and tested for significant
changes as previously described (Minor et al., 2011). For parametric
analysis of gene set enrichment (PAGE), a complete set of pathways in
the cell and gene ontology (GO) gene sets were obtained from http://
www.broadinstitute.org/gsea/msigdb/index.jsp.
Principal component analysis was performed on the replicate average
for the four groups: SAMR1-AL, SAMP8-AL, SAMR1-CR, and SAMP8-
CR. These tools are part of DIANE 1.0, a program developed by V.V.P
and available at http://www.grc.nia.nih.gov/branches/rrb/dna/
diane_software.pdf. Details of the method are described elsewhere
(Kim & Volsky, 2005).
Strain and treatment differences were evaluated through a Z ratio
calculation as previously described (Cheadle et al., 2003). In brief, raw
hybridization intensity data were log-transformed and normalized to
yield Z scores, which in turn were used to calculate a Z ratio value for
each gene in an experimental astrocyte culture with respect to its control
astrocyte culture. The Z ratio was calculated as the difference between
the observed gene Z scores for the experimental and the control groups,
and dividing by the standard deviation associated with the distribution of
these differences.
We analyzed the changes in gene expression in SAMP8 vs. SAMR1
(P8AL-R1AL), the effects induced by CR treatment in both strains (R1CR-
R1AL and P8CR-P8AL) and the changes in gene expression in SAMP8 vs.
SAMR1 after CR treatment (P8CR-R1CR). Z ratio values ≥+1.5 or ≤1.5
were chosen as cutoff values, defining increased and decreased
expression, respectively. Comparison of the gene expression between
all pairs of groups selected yielded a significance of P < 0.05. A complete
screen of gene sets belonging to 1688 pathways in the cell, and
involving 6281 genes, was analyzed to check for SAMP8 cell status and
CR-induced changes. In addition, changes in GO gene sets associated
with specific biological processes, cellular components, and molecular
functions were analyzed in a further search for age-related markers and
their response to CR. A Z score value for each gene set was calculated
according to the Z ratios of the corresponding genes. Again the cutoff
value was 1.5 and P < 0.05.
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Quantitative real-time PCR
For verification of specific microarray results, we performed reverse
transcription (RT) using a SuperScript III First-Strand Synthesis System
(Invitrogen) with random hexamers. Then, real-time quantitative (q) PCR
analysis was performed with a RT2 SYBR Green/ROX PCR Master Mix
(SuperArray Bioscience Corporation, Frederick, MD, USA) using gene-
specific primer pairs. GAPDH was used as housekeeping gene. Primer
sequences were designed according to NCBI Nucleotide BLAST database
(See Tables S6 and S7, Supporting information).
Analysis of senescent phenotype
Morphological changes were analyzed by phase contrast microscopy of
astrocyte cultures fixed with 4% paraformaldehyde (Sigma, St Louis,
MO, USA) and by confocal imaging after further immunostaining with
antiglial fibrillary acidic protein (GFAP, 1:500; Dako, Glostrup, Denmark),
followed by Alexa Fluor 546 (1:1000; Molecular Probes, Life Technol-
ogies, Alcobendas, Madrid, Spain). Oxidative damage was detected by
double immunostaining with antinitrotyrosine (1:50; Abcam, Cam-
bridge, UK), followed by Alexa Fluor 488 (1:1000; Molecular Probes).
Cell nuclei were counterstained with Hoechst bisbenzimide (Sigma).
Mitochondrial mass was visualized by staining fresh cultures with
MitoTracker Green FM (50 nM, 30 min; Molecular Probes). Presence of
replicative senescence was analyzed with the Senescence b-Galactosi-
dase Staining kit (Cell Signaling Technology, Danvers, MA, USA),
following manufacturer’s instructions.
Oxygen consumption rate
The oxygen consumption rate of SAMP8 and SAMR1 astrocytes was
determined under basal conditions, namely in the absence of inhibitors
or uncouplers. The resting respiration rate was determined in cultures
previously treated with AL or CR serum for 48 h. Cells were trypsinized
and resuspended in DMEM. Oxygen consumption of the intact cells was
monitored using a S1 Clark-type electrode of high sensitivity (Oxytherm,
Hansatech, Norfolk, UK) and calculated using specific software (Oxy-
graph Plus software; Hansatech). Results were obtained as nmol oxygen
consumed/min/106 cells.
Hydroperoxide generation
Oxidative stress in astrocyte cultures was studied using 20,70-dichloro-
fluorescin diacetate (DCFH-DA, Molecular Probes) to determine intra-
cellular hydroperoxide generation, as the main indicator of reactive
oxygen species (ROS). The analysis was performed in astrocytes seeded
in 96-well dishes, as previously described in detail (Garcıa-Matas et al.,
2010). Fluorescence induced by intracellular oxidation of the DCFH
probe to 20,70-dichlorofluorescein (DCF) was measured after 3 h of
incubation in HEPES-buffered saline. Fluorescence was normalized by
the protein content of each well and expressed as a percentage of the
control. All astrocytes were pretreated with AL or CR serum for 48 h.
For the last 24 h, the cultures were challenged with 500 lM of
hydrogen peroxide added to the media or incubated in control
conditions.
Aconitase 2 levels
Changes of the antioxidant mitochondrial enzyme aconitase 2 were
determined with the Aconitase 2 Profiling ELISA kit (Abcam), following
the manufacturer’s instructions. Analysis was performed in mitochon-
drial extracts obtained with the Mitochondrial Isolation Kit for Cultured
Cells (Pierce, Rockford, IL, USA).
Mitochondrial membrane potential
A decrease in the mitochondrial membrane potential (MMP) of SAMP8
astrocyte cultures in comparison with SAMR1 ones was shown using the
fluorescent probe rhodamine 123, as previously described (Garcıa-Matas
et al., 2008). Rhodamine 123 accumulation in the mitochondria is driven
by the MMP. Next, we treated the astrocyte cultures with MMP
uncouplers and mitochondrial complex inhibitors for 1 h after rhoda-
mine 123 loading. Increased fluorescence in SAMP8 compared with
SAMR1 cultures indicated a higher reduction of MMP induced by a
higher sensitivity to the mitochondrial toxin. Results were calculated as
fluorescence units per lg of protein per well and are shown as
percentage of the control.
In another set of experiments, we aimed to confirm SAMP8
mitochondrial impairment using the alternative probe tetramethylrhod-
amine methyl ester (TMRM, Molecular Probes) and to study the effects
of CR treatment. TMRM accumulation in mitochondria is also dependent
on the MMP and may have some advantages over rhodamine 123 for
rapid in situ quantitative determination. The reduced hydrophobic
character of the TMRM molecule improves its dynamics. We simulta-
neously determined the mitochondrial mass content using nonyl acridine
orange (NAO, Molecular Probes). NAO binds to cardiolipin in the
mitochondria. Cultures in 96-well plates were previously treated with AL
or CR serum for 48 h. Then, cells were washed with HBSS and loaded
with 1 lM of NAO. After 5 min of incubation at 37°C, cultures were
loaded with 10 lM of TMRM and incubated for another 20 min. Finally,
cultures were washed, and the fluorescence of both probes was
measured at 535 nm excitation/590 nm emission and 490 nm excita-
tion/535 nm emission, for TMRM and NAO, respectively.
Western blotting
Cultured astrocytes were washed in cold PBS and lysed in ice-cold RIPA
buffer (10 mM PBS, 1% Igepal AC-630, 0.5% sodium deoxycholate, 2%
sodium dodecyl sulfate) containing a protease inhibitor cocktail
(Complete tablets; Boehringer Mannheim, Mannheim, Germany),
1 mM sodium orthovanadate, and 5 mM sodium fluoride. The homo-
genates were centrifuged at 4°C, and the supernatants used to evaluate
protein expression by Western immunoblotting as described (Garcıa-
Matas et al., 2008). Protein extracts were probed with a cocktail of five
antibodies against selected proteins of mitochondrial complexes (Mito-
Profile Total OXPHOS Rodent; Abcam). Protein extracts were also tested
for oxidized proteins using an OxyBlot Protein Oxidation kit (Chemicon
International, Temecula, CA, USA) following the manufacturer’s instruc-
tions. Protein loading was normalized by staining membranes with
Coomassie blue. Densitometrical analyses were performed with Quantity
One software (Bio-Rad, Hercules, CA, USA).
Statistics
For the microarray analysis, the significance of Z score values was tested
using JMP 6.0 software, included in the DIANE 1.0 program (see microarray
methods). All the other results were expressed as mean  SEM. Where
CR vs. AL treatment was assayed in SAMR1 and SAMP8 cultures, data
were analyzed by two-way ANOVA followed by post hoc Bonferroni’s
test. Paired data were analyzed with Student’s t-test and correlations
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with Pearson test. These statistics were performed using GRAPHPAD PRISM
software (v4.02; La Jolla, San Diego, CA, USA).
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